132 related articles for article (PubMed ID: 14972536)
1. Poliovirus mutants excreted by a chronically infected hypogammaglobulinemic patient establish persistent infections in human intestinal cells.
Labadie K; Pelletier I; Saulnier A; Martin J; Colbère-Garapin F
Virology; 2004 Jan; 318(1):66-78. PubMed ID: 14972536
[TBL] [Abstract][Full Text] [Related]
2. Reduced apoptosis in human intestinal cells cured of persistent poliovirus infection.
Labadie K; Saulnier A; Martin-Latil S; Colbère-Garapin F
J Virol; 2007 Mar; 81(6):3033-6. PubMed ID: 17192301
[TBL] [Abstract][Full Text] [Related]
3. One amino acid change on the capsid surface of poliovirus sabin 1 allows the establishment of persistent infections in HEp-2c cell cultures.
Pelletier I; Duncan G; Colbère-Garapin F
Virology; 1998 Feb; 241(1):1-13. PubMed ID: 9454712
[TBL] [Abstract][Full Text] [Related]
4. Expression of mutated poliovirus receptors in human neuroblastoma cells persistently infected with poliovirus.
Pavio N; Couderc T; Girard S; Sgro JY; Blondel B; Colbère-Garapin F
Virology; 2000 Sep; 274(2):331-42. PubMed ID: 10964776
[TBL] [Abstract][Full Text] [Related]
5. Poliovirus vaccine strains detected in stool specimens of immunodeficient children in South Africa.
Pavlov DN; Van Zyl WB; Kruger M; Blignaut L; Grabow WO; Ehlers MM
Diagn Microbiol Infect Dis; 2006 Jan; 54(1):23-30. PubMed ID: 16290028
[TBL] [Abstract][Full Text] [Related]
6. Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication.
Minor P
Vaccine; 2009 May; 27(20):2649-52. PubMed ID: 19428874
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa.
Pavlov DN; Van Zyl WB; Van Heerden J; Kruger M; Blignaut L; Grabow WO; Ehlers MM
J Appl Microbiol; 2006 Dec; 101(6):1367-79. PubMed ID: 17105568
[TBL] [Abstract][Full Text] [Related]
8. Isolation of recombinant type 2 vaccine-derived poliovirus (VDPV) from a Nigerian child.
Adu F; Iber J; Bukbuk D; Gumede N; Yang SJ; Jorba J; Campagnoli R; Sule WF; Yang CF; Burns C; Pallansch M; Harry T; Kew O
Virus Res; 2007 Jul; 127(1):17-25. PubMed ID: 17449127
[TBL] [Abstract][Full Text] [Related]
9. Two amino acid substitutions in the type 3 poliovirus capsid contribute to the establishment of persistent infection in HEp-2c cells by modifying virus-receptor interactions.
Duncan G; Pelletier I; Colbère-Garapin F
Virology; 1998 Feb; 241(1):14-29. PubMed ID: 9454713
[TBL] [Abstract][Full Text] [Related]
10. Cell clones cured of persistent poliovirus infection display selective permissivity to the wild-type poliovirus strain Mahoney and partial resistance to the attenuated Sabin 1 strain and Mahoney mutants.
Calvez V; Pelletier I; Couderc T; Pavio-Guédo N; Blondel B; Colbère-Garapin F
Virology; 1995 Oct; 212(2):309-22. PubMed ID: 7571400
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of vaccine-derived polioviruses in sewage and river water in South Africa.
Pavlov DN; Van Zyl WB; Van Heerden J; Grabow WO; Ehlers MM
Water Res; 2005 Sep; 39(14):3309-19. PubMed ID: 15996707
[TBL] [Abstract][Full Text] [Related]
12. Poliovirus persistence in human cells in vitro.
Colbère-Garapin F; Jacques S; Drillet AS; Pavio N; Couderc T; Blondel B; Pelletier I
Dev Biol (Basel); 2001; 105():99-104. PubMed ID: 11763344
[TBL] [Abstract][Full Text] [Related]
13. Isolation of a type 3 vaccine-derived poliovirus (VDPV) from an Iranian child with X-linked agammaglobulinemia.
Shahmahmoodi S; Parvaneh N; Burns C; Asghar H; Mamishi S; Tabatabaie H; Chen Q; Teimourian S; Gooya MM; Esteghamati AR; Mousavi T; Yousefi M; Farrokhi K; Mashlool M; Kew O; Nategh R
Virus Res; 2008 Oct; 137(1):168-72. PubMed ID: 18674576
[TBL] [Abstract][Full Text] [Related]
14. The pathogenesis of poliomyelitis: what we don't know.
Nathanson N
Adv Virus Res; 2008; 71():1-50. PubMed ID: 18585526
[TBL] [Abstract][Full Text] [Related]
15. Oral poliovaccine: will it help eradicate polio or cause the next epidemic?
Shulman LM; Manor Y; Sofer D; Swartz T; Mendelson E
Isr Med Assoc J; 2006 May; 8(5):312-5. PubMed ID: 16805227
[TBL] [Abstract][Full Text] [Related]
16. Complete cure of persistent virus infections by antiviral siRNAs.
Saulnier A; Pelletier I; Labadie K; Colbère-Garapin F
Mol Ther; 2006 Jan; 13(1):142-50. PubMed ID: 16157509
[TBL] [Abstract][Full Text] [Related]
17. Persistent infection of human erythroblastoid cells by poliovirus.
Lloyd RE; Bovee M
Virology; 1993 May; 194(1):200-9. PubMed ID: 8386873
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of prolonged and chronic poliovirus excretion among persons with primary immune deficiency disorders in Sri Lanka.
de Silva R; Gunasena S; Ratnayake D; Wickremesinghe GD; Kumarasiri CD; Pushpakumara BA; Deshpande J; Kahn AL; Sutter RW
Vaccine; 2012 Dec; 30(52):7561-5. PubMed ID: 23099333
[TBL] [Abstract][Full Text] [Related]
19. Update on vaccine-derived polioviruses--worldwide, January 2008-June 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(36):1002-6. PubMed ID: 19763076
[TBL] [Abstract][Full Text] [Related]
20. Update on vaccine-derived polioviruses--worldwide, January 2006-August 2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(38):996-1001. PubMed ID: 17898693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
